Page last updated: 2024-11-01

norfloxacin and Obstructive Lung Diseases

norfloxacin has been researched along with Obstructive Lung Diseases in 2 studies

Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wijnands, WJ1
Vree, TB1
Baars, AM1
van Herwaarden, CL1
Tamura, G1
Satoh, K1
Ohtsu, H1
Fujimoto, Y1
Aizawa, T1
Sakai, K1
Mue, S1
Takishima, T1

Other Studies

2 other studies available for norfloxacin and Obstructive Lung Diseases

ArticleYear
The influence of the 4-quinolones ciprofloxacin, pefloxacin and ofloxacin on the elimination of theophylline.
    Pharmaceutisch weekblad. Scientific edition, 1987, Dec-11, Volume: 9 Suppl

    Topics: Aged; Anti-Infective Agents; Ciprofloxacin; Female; Humans; Lung Diseases, Obstructive; Male; Metabo

1987
[Norfloxacin does not raise theophylline concentrations in plasma].
    Arerugi = [Allergy], 1987, Volume: 36, Issue:5

    Topics: Aged; Drug Interactions; Drug Therapy, Combination; Female; Humans; Lung Diseases, Obstructive; Male

1987